跳至主要内容
临床试验/NCT04140552
NCT04140552招募中不适用

Chinese Research Group of Gallbladder Cancer

Shanghai Jiao Tong University School of Medicine55 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2008年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
55
主要终点
Overall Survival

研究概览

简要总结

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

详细描述

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • Patients with accessible electronic medical record

排除标准

  • Patients with undetermined primary site of cancer.

结局指标

主要结局

Overall Survival

时间窗: 5 years

The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.

次要结局

未报告次要终点

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yingbin Liu, MD, PhD, FACS

Prof.

Shanghai Jiao Tong University School of Medicine

研究点 (55)

Loading locations...

相似试验